Login  |  Register

Statistics

  • Active Listings: 20392
  • Pending Listings: 0
  • Todays Listings: 0
  • Total Categories: 43
  • Sub Categories: 1315

Partners

CABOMETYX™: now approved for advanced RCC

CABOMETYX™ (cabozantinib) is approved in patients who have received prior anti-angiogenic therapy for advanced RCC.

Alexa Traffic


Listing Links